Identification of the First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief

Francesca Gado, Lorenzo Di Cesare Mannelli, Elena Lucarini, Simone Bertini, Elena Cappelli, Maria Digiacomo, Lesley A. Stevenson, Marco Macchia, Tiziano Tuccinardi, Carla Ghelardini, Roger G. Pertwee, Clementina Manera*

*Corresponding author for this work

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The direct activation of cannabinoid receptors (CBRs) results in several beneficial effects; therefore several CBRs ligands have been synthesized and tested in vitro and in vivo. However, none of them reached an advanced phase of clinical development due mainly to side effects on the CNS. Medicinal chemistry approaches are now engaged to develop allosteric modulators that might offer a novel therapeutic approach to achieve potential therapeutic benefits avoiding inherent side effects of orthosteric ligands. Here we identify the first ever synthesized positive allosteric modulator (PAM) that targets CB2Rs. The evidence for this was obtained using [3H]CP55940 and [35S]GTPγS binding assays. This finding will be useful for the characterization of allosteric binding site(s) on CB2Rs which will be essential for the further development of CB2R allosteric modulators. Moreover, the new CB2R PAM displayed antinociceptive activity in vivo in an experimental mouse model of neuropathic pain, raising the possibility that it might be a good candidate for clinical development.

Original languageEnglish
Pages (from-to)276-287
Number of pages12
JournalJournal of Medicinal Chemistry
Volume62
Issue number1
Early online date10 Jul 2018
DOIs
Publication statusPublished - 10 Jan 2019

Fingerprint

Cannabinoid Receptor CB2
Cannabinoid Receptors
Neuralgia
Allosteric Site
Ligands
Pharmaceutical Chemistry
Theoretical Models
Binding Sites
Therapeutics
In Vitro Techniques
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol

Keywords

  • ENDOCANNABINOID SYSTEM
  • CANNABINOID RECEPTOR
  • BINDING
  • INHIBITOR
  • SITE

ASJC Scopus subject areas

  • Drug Discovery
  • Molecular Medicine

Cite this

Identification of the First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief. / Gado, Francesca; Di Cesare Mannelli, Lorenzo; Lucarini, Elena; Bertini, Simone; Cappelli, Elena; Digiacomo, Maria; Stevenson, Lesley A.; Macchia, Marco; Tuccinardi, Tiziano; Ghelardini, Carla; Pertwee, Roger G.; Manera, Clementina.

In: Journal of Medicinal Chemistry, Vol. 62, No. 1, 10.01.2019, p. 276-287.

Research output: Contribution to journalArticle

Gado, F, Di Cesare Mannelli, L, Lucarini, E, Bertini, S, Cappelli, E, Digiacomo, M, Stevenson, LA, Macchia, M, Tuccinardi, T, Ghelardini, C, Pertwee, RG & Manera, C 2019, 'Identification of the First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief', Journal of Medicinal Chemistry, vol. 62, no. 1, pp. 276-287. https://doi.org/10.1021/acs.jmedchem.8b00368
Gado, Francesca ; Di Cesare Mannelli, Lorenzo ; Lucarini, Elena ; Bertini, Simone ; Cappelli, Elena ; Digiacomo, Maria ; Stevenson, Lesley A. ; Macchia, Marco ; Tuccinardi, Tiziano ; Ghelardini, Carla ; Pertwee, Roger G. ; Manera, Clementina. / Identification of the First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief. In: Journal of Medicinal Chemistry. 2019 ; Vol. 62, No. 1. pp. 276-287.
@article{993f5f550af74c0e8da669799e304f90,
title = "Identification of the First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief",
abstract = "The direct activation of cannabinoid receptors (CBRs) results in several beneficial effects; therefore several CBRs ligands have been synthesized and tested in vitro and in vivo. However, none of them reached an advanced phase of clinical development due mainly to side effects on the CNS. Medicinal chemistry approaches are now engaged to develop allosteric modulators that might offer a novel therapeutic approach to achieve potential therapeutic benefits avoiding inherent side effects of orthosteric ligands. Here we identify the first ever synthesized positive allosteric modulator (PAM) that targets CB2Rs. The evidence for this was obtained using [3H]CP55940 and [35S]GTPγS binding assays. This finding will be useful for the characterization of allosteric binding site(s) on CB2Rs which will be essential for the further development of CB2R allosteric modulators. Moreover, the new CB2R PAM displayed antinociceptive activity in vivo in an experimental mouse model of neuropathic pain, raising the possibility that it might be a good candidate for clinical development.",
keywords = "ENDOCANNABINOID SYSTEM, CANNABINOID RECEPTOR, BINDING, INHIBITOR, SITE",
author = "Francesca Gado and {Di Cesare Mannelli}, Lorenzo and Elena Lucarini and Simone Bertini and Elena Cappelli and Maria Digiacomo and Stevenson, {Lesley A.} and Marco Macchia and Tiziano Tuccinardi and Carla Ghelardini and Pertwee, {Roger G.} and Clementina Manera",
year = "2019",
month = "1",
day = "10",
doi = "10.1021/acs.jmedchem.8b00368",
language = "English",
volume = "62",
pages = "276--287",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "AMER CHEMICAL SOC",
number = "1",

}

TY - JOUR

T1 - Identification of the First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief

AU - Gado, Francesca

AU - Di Cesare Mannelli, Lorenzo

AU - Lucarini, Elena

AU - Bertini, Simone

AU - Cappelli, Elena

AU - Digiacomo, Maria

AU - Stevenson, Lesley A.

AU - Macchia, Marco

AU - Tuccinardi, Tiziano

AU - Ghelardini, Carla

AU - Pertwee, Roger G.

AU - Manera, Clementina

PY - 2019/1/10

Y1 - 2019/1/10

N2 - The direct activation of cannabinoid receptors (CBRs) results in several beneficial effects; therefore several CBRs ligands have been synthesized and tested in vitro and in vivo. However, none of them reached an advanced phase of clinical development due mainly to side effects on the CNS. Medicinal chemistry approaches are now engaged to develop allosteric modulators that might offer a novel therapeutic approach to achieve potential therapeutic benefits avoiding inherent side effects of orthosteric ligands. Here we identify the first ever synthesized positive allosteric modulator (PAM) that targets CB2Rs. The evidence for this was obtained using [3H]CP55940 and [35S]GTPγS binding assays. This finding will be useful for the characterization of allosteric binding site(s) on CB2Rs which will be essential for the further development of CB2R allosteric modulators. Moreover, the new CB2R PAM displayed antinociceptive activity in vivo in an experimental mouse model of neuropathic pain, raising the possibility that it might be a good candidate for clinical development.

AB - The direct activation of cannabinoid receptors (CBRs) results in several beneficial effects; therefore several CBRs ligands have been synthesized and tested in vitro and in vivo. However, none of them reached an advanced phase of clinical development due mainly to side effects on the CNS. Medicinal chemistry approaches are now engaged to develop allosteric modulators that might offer a novel therapeutic approach to achieve potential therapeutic benefits avoiding inherent side effects of orthosteric ligands. Here we identify the first ever synthesized positive allosteric modulator (PAM) that targets CB2Rs. The evidence for this was obtained using [3H]CP55940 and [35S]GTPγS binding assays. This finding will be useful for the characterization of allosteric binding site(s) on CB2Rs which will be essential for the further development of CB2R allosteric modulators. Moreover, the new CB2R PAM displayed antinociceptive activity in vivo in an experimental mouse model of neuropathic pain, raising the possibility that it might be a good candidate for clinical development.

KW - ENDOCANNABINOID SYSTEM

KW - CANNABINOID RECEPTOR

KW - BINDING

KW - INHIBITOR

KW - SITE

UR - http://www.scopus.com/inward/record.url?scp=85049863551&partnerID=8YFLogxK

UR - http://www.mendeley.com/research/identification-first-synthetic-allosteric-modulator-cb-2-receptors-evidence-efficacy-neuropathic-pai

U2 - 10.1021/acs.jmedchem.8b00368

DO - 10.1021/acs.jmedchem.8b00368

M3 - Article

VL - 62

SP - 276

EP - 287

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 1

ER -